| AR |
P10275
|
androgen receptor
|
Nuclear receptor
|
0.99 |
0.351 |
0.846 |
| C4A |
P0C0L4 P0C0L5
|
complement C4A (Rodgers blood group)
|
Enzyme modulator
|
1.5E-11 |
0.563 |
0.769 |
| C4B |
P0C0L4 P0C0L5
|
complement C4B (Chido blood group)
|
Enzyme modulator
|
0.83 |
0.603 |
0.808 |
| C4B_2 |
P0C0L4 P0C0L5
|
complement component 4B (Chido blood group), copy 2
|
|
|
0.670 |
0.731 |
| CSF2 |
P04141
|
colony stimulating factor 2
|
Signaling
|
0.83 |
0.330 |
0.962 |
| CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
| DKK1 |
O94907
|
dickkopf WNT signaling pathway inhibitor 1
|
|
0.17 |
0.439 |
0.885 |
| FPR2 |
P25090
|
formyl peptide receptor 2
|
G-protein coupled receptor
|
0.40 |
0.547 |
0.769 |
| GH1 |
P01241
|
growth hormone 1
|
Signaling
|
3.0E-02 |
0.373 |
0.923 |
| GLO1 |
Q04760
|
glyoxalase I
|
|
9.7E-07 |
0.537 |
0.769 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| HLA-DOA |
P06340
|
major histocompatibility complex, class II, DO alpha
|
Immune response
|
3.0E-10 |
0.509 |
0.808 |
| IGF2 |
P01344
|
insulin like growth factor 2
|
|
4.4E-02 |
0.390 |
0.885 |
| IRS1 |
P35568
|
insulin receptor substrate 1
|
|
2.4E-02 |
0.488 |
0.769 |
| NR1I2 |
O75469
|
nuclear receptor subfamily 1 group I member 2
|
Nuclear receptor
|
7.3E-09 |
0.418 |
0.846 |
| NR3C1 |
P04150
|
nuclear receptor subfamily 3 group C member 1
|
Nuclear receptor
|
0.97 |
0.393 |
0.885 |
| POMC |
P01189
|
proopiomelanocortin
|
|
1.2E-04 |
0.356 |
0.846 |
| REN |
P00797
|
renin
|
Enzyme
|
2.4E-07 |
0.370 |
0.923 |
| TNFRSF11B |
O00300
|
TNF receptor superfamily member 11b
|
|
0.16 |
0.422 |
0.808 |
| TNFRSF1B |
P20333
|
TNF receptor superfamily member 1B
|
|
0.50 |
0.425 |
0.885 |
| TNFSF11 |
O14788
|
TNF superfamily member 11
|
Signaling
|
4.9E-03 |
0.453 |
0.846 |
| TNXB |
P22105
|
tenascin XB
|
|
1.9E-02 |
0.572 |
0.731 |